Ultimate Guide to Stem Cell use in Clinical Trials and Comparison to CRISPR

Phantastic Topline Clinical Results with sublingual epinephrine AQST-109 Aquestive Therapeutics

What is FDA Breakthrough Therapy Designation? What is EMA PRIME Medicine Status?

CMS Final Ruling on Alzheimer Drugs that are monoclonal antibodies against amyloid plaque

First ever pediatric in-vivo CRISPR gene editing patient - a step towards curing blindness

A vaccine against Alzheimer's disease? Yes, meet Araclon Biotech!

Intellia Therapeutics hit 2 key milestones in their NTLA-5001 program against acute myeloid leukemia

Medicare may not cover a new type of Alzheimer drugs widely if CMS get their way - Bad news for AD

What is FDA Fast Track status? What is EMA Accelerated Assessment?

Intellia Therapeutics provide promising interim update on in-vivo CRISPR gene editing NTLA-2001

NanoDimension - $NNDM: Cutting Edge 3d Printing of Electronics and Highly Undervalued

Aquestive Therapeutics Updates for AQST-109 Sublingual Epinephrine

Pfizer - Beam Therapeutics Collaboration: There's more in it for Beam than you think!

Tough Questions on Investing into Cassava Sciences and Biotech Answered

The Investor's Guide to Understanding CAR T-Cell Cancer Therapy - Military Warfare Analogy

Can getting enough sleep make you a better investor? Find out!

Aquestive Therapeutics - An even better investment opportunity following recent drop in AQST?

Aquestive Therapeutics - Delivering known Medications in a More Convenient Way

Cassava Sciences: Friend or Fraud? An objective view on the Controversy - Part 1

CRISPR Therapeutics and ViaCyte Tackling Type 1 Diabetes

Becoming a better investor - discount shopping

An Update on Bluebird Bio and Unpacking the Hidden Bombshell

Cassava Sciences - One Stop Shop For Fixing Alzheimer's Disease - Opportunity for Huge Profits

Bionano Genomics - What you need to understand about FDA approval of the Saphyr OGM System

Explaining the patient numbers in Crispr Therapeutics' CTX110 Phase I Clinical Trial

CRISPR Therapeutics Clinical Trial Update on Allogeneic CAR-T Cell Treatment

New Clinical Trial for Intellia Therapeutics - in-Vivo CRISPR gene editing NTLA 2002

Liquid Biopsies - A New Era of Cancer Screening Gathers Interest from Investors and Patients

New Clinical Trial soon for Intellia Therapeutics - FDA accepts IND for NTLA-5001

On the fence to get Covid vaccine? Must-watch video to help you decide.

Ride up the investment elevator with this new IPO gene editing stock - Caribou Biosciences

Which company could be a commercial Match made in Heaven for Crispr Therapeutics and Vertex?

Groundbreaking News from Intellia Therapeutics

Why is Bioline Rx Stock BLRX not reacting to positive phase 3 news?

Comparing Crispr Therapeutics' CTX001 vs. Bluebird Bio's lovo-cel Sickle Cell Disease Clinical Data

Comparing Crispr Therapeutics' CTX001 vs. Bluebird Bio's Beti-Cel Latest Clinical Data

HealthWealth Investor Toolkit: Beginner's Guide to understanding Regulatory Approval of Orphan Drugs

Bluebird Bio Updates and Zynteglo caught in reimbursement negotiations

Beam Therapeutics getting one step closer to clinical trials

HealthWealth Investor Toolkit: Beginner's Guide to understanding Orphan Drug Status

Introducing SQZ Biotech: Does squeezing cells result in successful living cancer treatment?

CRISPR Gene Editing Part 2: Race to first cure for Beta Thalassemia and Sickle Cell Disease

CRISPR Gene editing First to market with cure for Beta Thalassemia and Sickle Cell to make millions

Rationale for CRISPR Therapeutics potential first product commercialization date for CTX001

BiolineRx report successful Phase III clinical data for their Motixafortide (BL-8040) compound

Intellia Therapeutics Clinical Pipeline and Q1 2021 Updates

CRISPR Therapeutics making headway to first commercial product

10x Gene Editing Investing: Understanding the uniqueness of Beam Therapeutics - Part 2

Novocure Clinical Trial Update - Investor Reward

10x Gene Editing Investing: Background to understanding the uniqueness of Beam Therapeutics - Part1

Big Update on Bluebird Bio

Benefiting as an Investor from Palantir and FDA Contract

The 10x Investment into Gene Editing - Comparing BLUE vs. CRSP

The 10x Investment into Gene Editing - Comparing CRSP vs. EDIT

How to maintain cleaner teeth on the go when you cannot brush

Are you taking better care of your car than your teeth? Discover what preventive maintenance can do.